Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 1826-1833

  Boyle, Kathleen A ^a   Compton, Teresa ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING KINETICS; CHO CELL; CONTROLLED STUDY; FIBROBLAST CULTURE; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

EID: 0031910646     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.1826-1833.1998     Document Type: Article

References (61)

1. Adlish, J. D., R. S. Lahijani, and S. C. St. Jeor. 1990. Identification of a putative cell receptor for human cytomegalovirus. Virology 176:337-345.
2. Alford, C. A., and W. J. Britt. 1990. Cytomegalovirus, p. 1981-2010. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Virology. Raven Press, New York, N.Y.
3. Berry, N. J., D. M. Burns, G. Wannamethee, J. E. Grundy, S. F. Lui, H. G. Prentice, and P. D. Griffiths. 1988. Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J. Med. Virol. 24:385-393.
4. Boyle, K. A., and T. Compton. Unpublished results.
5. Britt, W. J. 1984. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 135: 369-378.
6. Britt, W. J., and D. Auger. 1986. Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J. Virol. 58:185-191.
7. Britt, W. J., and L. G. Vugler. 1989. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J. Virol. 63:403-410.
8. Britt, W. J., L. Vugler, E. J. Butfiloski, and E. B. Stephens. 1990. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J. Virol. 64:1079-1085.
9. Britt, W. J., and L. G. Vugler. 1992. Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J. Virol. 66: 6747-6754.
10. Cai, W., B. Gu, and S. Person. 1988. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:2596-2604.
11. Carlson, C., W. J. Britt, and T. Compton. 1997. Expression, purification and characterization of a soluble form of human cytomegalovirus glycoprotein B. Virology 239:198-205.
12. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
13. Compton, T., R. R. Nepomuceno, and D. M. Nowlin. 1992. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191:387-395.
14. Compton, T., D. M. Nowlin, and N. R. Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-841.
15. Compton, T. 1993. An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67:3644-3648.
16. Cranage, M. P., T. Kouzarides, A. T. Bankler, S. C. Satchwell, K. M. Weston, P. Tomlinson, B. G. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith. 1986. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccina virus. EMBO J. 5:3057-3063.
17. Eberle, R., and D. Black. 1993. Sequence analysis of herpes simplex virus gB gene homologs of two platyrrhine monkey alpha-herpesviruses. Arch. Virol. 129:167-182.
18. Esko, J. D., T. E. Stewart, and W. H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82:3197-3201.
19. Esko, J. D., K. S. Rostand, and J. L. Weinke. 1988. Tumor formation dependent on proteoglycan biosynthesis. Science 241:1092-1094.
20. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1991. Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Virus Res. 22:25-39.
21. Harrold, R. E., A. Marchini, S. Fruehing, and R. Longnecker. 1996. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo. J. Virol. 70:2049-2054.
22. Herold, B. C., R. J. Visalli, N. Susmarski, C. R. Brandt, and P. G. Spear. 1994. Glycoprotein C-independent binding of herpes simplex to cells requires cell surface heparan sulfate and glycoprotein B. J. Gen. Virol. 75: 1211-1222.
23. Ho, M. 1990. Epidemiology of cytomegalovirus infection. Rev. Infect. Dis. 12:701S-710S.
24. Huber, M., and T. Compton. 1997. Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol. 71:5391-5398.
25. Johnson, D. C., R. L. Burke, and T. Gregory. 1990. Soluble forms of herpes simples virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J. Virol. 64:2569-2576.
26. Kari, B., and R. Gehrz. 1992. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66:1761-1764.
27. Kari, B., and R. Gehrz. 1993. Structure, composition and heparin binding properties of human cytomegalovirus glycoprotein complex designated gC-II. J. Gen. Virol. 74:255-264.
28. Keay, S., and B. Baldwin. 1992. The human fibroblast receptor for gp8f of human cytomegalovirus is a phosphorylated glycoprotein. J. Virol. 66:4834-4838.
29. Keay, S., and B. Baldwin. 1995. Update on the 92.5 kDa putative HCMV fusion receptor. Scand. J. Infect. Dis. 99:32-33.
30. Kopp, A., and T. C. Mettenleiter. 1992. Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein I of bovine herpesvirus 1. J. Virol. 66:2754-2764.
31. Landau, N. R., M. Warton, and D. R. Littman. 1988. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 334:159-162.
32. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennie, C. Shimasaki, D. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
33. Lee, S. K., T. Compton, and R. Longnecker. 1997. Failure to complement infectivity of EBV and HSV-1 glycoprotein B (gB) deletion mutants with gBs from different human herpesvirus subfamilies. Virology 237:170-181.
34. Li, Y., S. van Drunen Littel-van den Hurk, L. A. Babiuk, and X. Liang. 1995. Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB. J. Virol 69:4758-4768.
35. Marshall, G. S., G. P. Rabalais, G. G. Stout, and S. L. Waldeyer. 1992. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J. Infect. Dis. 165:381-384.
36. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382-385.
37. Mettenleiter, T. C., and P. G. Spear. 1994. Glycoprotein B (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J. Virol. 68:500-504.
38. Miethke, A., G. M. Keil, F. Weiland, and T. C. Mettenleiter. 1995. Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J. Gen. Virol. 76:1623-1635.
39. Misra, V., and E. L. Blewett. 1991. Construction of herpes simplex viruses that are pseudodiploid for the glycoprotein B gene: a strategy for studying the function of an essential herpesvirus gene. J. Gen. Virol. 72:385-392.
40. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
41. Navarro, D., P. Paz, S. Tugizov, K. Topp, J. La Vail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
42. Nemerow, G. R., C. Mold, V. Keivens Schwend, V. Tollefson, and N. R. Cooper. 1987. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 61:1416-1420.
43. Neyts, J., R. Snoeck, D. Schols, J. Balzarini, J. D. Esko, S. A. Van, and C. E. De. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48-58.
44. Nowlin, D. M., N. R. Cooper, and T. Compton. 1991. Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J. Virol. 65: 3114-3121.
45. Pereira, L. 1994. Function of glycoprotein B homologues of the family Herpesviridae. Infect. Agents Dis. 3:9-28.
46. Pietropaolo, R. L., and T. Compton. 1997. Direct interaction between human cytomegalovirus glycoprotein B and cellular annexin II. J. Virol. 71:9803-9807.
47. Rauh, I., F. Weiland, F. Fehler, G. Keil, and T. C. Mettenleiter. 1991. Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J. Virol. 65:621-631.
48. Ross, L. J., M. Sanderson, S. D. Scott, M. M. Binns, T. Doel, and B. Milne. 1989. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 70:1789-1804.
49. Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:660-672.
50. Sisk, W. P., J. D. Bradley, R. J. Leipold, A. M. Stoltzfus, M. Ponce de Leon, M. Hilf, C. Peng, G. H. Cohen, and R. J. Eisenberg. 1994. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J. Virol. 68:766-775.
51. Smith, D., R. Byrn, S. Marsters, T. Gregory, J. Groopman, and D. Capon. 1987. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 238:1704-1707.
52. Soderberg, C., T. D. Giugni, J. A. Zaia, S. Larsson, J. M. Walhberg, and E. Moller. 1993. CD13 (human aminopeptidase) mediates human cytomegalovirus infection. J. Virol. 67:6576-6585.
53. Spaete, R. R., A. Sazena, P. I. Scott, G. J. Song, W. S. Probert, W. J. Britt, W. Gibson, L. Rasmussen, and C. Pachl. 1990. Sequence requirements of proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. J. Virol. 64:2922-2931.
54. Spaete, R. R., R. M. Thayer, W. S. Probert, F. R. Masiarz, S. H. Chamberlain, L. Rasmussen, T. C. Merigan, and C. Pachl. 1988. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207-225.
55. Tal-Singer, R., C. Peng, M. Ponce de Leon, W. R. Abrams, B. W. Banfield, F. Tufaro, G. H. Cohen, and R. J. Eisenberg. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
56. Tanner, J., J. Weis, D. T. Fearon, Y. Whang, and E. Kieff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203-213.
57. Tanner, J., Y. Whang, J. Sample, A. Sears, and E. Kieff. 1988. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus absorption to lymphocytes. J. Virol. 62:4452-4464.
58. Taylor, H. P., and N. R. Cooper. 1990. The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. J. Virol. 64:2484-2490.
59. Tugizov, S., D. Navarro, P. Paz, Y. Wang, I. Qadri, and L. Pereira. 1994. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology 201:263-276.
60. Vey, M., W. Schafer, B. Reis, R. Ohuchi, W. J. Britt, W. Garten, H. D. Klenk, and K. Radsak. 1995. Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206:746-749.
61. Whitbeck, J. C., C. Peng, H. Lou, R. Xu, S. H. Willis, M. Ponce de Leon, T. Peng, A. V. Nicola, R. I. Montgomery, M. S. Warner, A. M. Soulika, L. A. Spruce, W. T. Moore, J. D. Lambris, P. G. Spear, G. H. Cohen, and R. J. Eisenberg. 1997. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71:6083-6093.